Top liver disease conference showcases positive clinical data from Yaqrit’s technologies

NEXT STORY
OSE Immunotherapeutics Reports on its 2021 Virtual Combined General Shareholder’s Meeting
PREV STORY
Axiom Presents “Unified Platforms: How to Address the Complexity of Oncology Studies to Better Support Your Sites” at Clinical Operations in Oncology Trials 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance

Stealth start-up company debuts with support from NIH and Leading Immuno-Oncology ExpertsHOUSTON, June 19, ...

author_avatar
NASDAQ Market News

AB Science granted authorization to initiate phase 3 confirmatory study of masitinib in indolent systemic mastocytosis

author_avatar
NASDAQ Market News

Global Telepresence Robots (Stationary & Mobile) Markets, Forecast & Opportunities, 2027

author_avatar
NASDAQ Market News